Abstract
The cytokine channel's mechanism for self-regulation involves the application of antagonistic cytokines that are synthesized to connect to the receptors and release soluble cytokine receptors. The very first receptor antagonist of cytokine that was naturally present was interleukin-1 receptor antagonist (IL-1Ra). The IL-1Ra protein forms are disinfected from supernatants of cultured monocytes on stacked IgG. The family of IL-1 consists of IL-1a, IL-1I3 and IL-1Ra. Human monocytes regulate the production of IL-Ra. IL-Ra takes part in normal physiological functions by using specific antibodies, and acts as an anti-inflammatory agent. IL-Ra is synthesized in the tissues during the period of active disease and can be systematically measured and/or estimated. Maintenance of the levels of IL-Ra and IL-1 is the main factor for host resistance in patients during diseased conditions, as IL-Ra acts as an inherent regulator of various inflammatory responses. In this article, we focuse on how IL-Ra is synthesized and performs its functions once the inflammatory responses are activated.